Wishlist
Compare
Subscribe
Login
Home Medicine
Shop
Page
About Us
Contact Us
FAQs
Terms Of Use
5-Fu/Leucovorin (2)
6-Mp-Containing Pediatric All Protocols (1)
7+3 (1)
7+3 + Midostaurin (2)
Abiraterone + Androgen-Deprivation Therapy (Adt) (10)
Abiraterone + Prednisone/Prednisolone (10)
Abvd (1)
Abvd Alternatives (1)
Abvd Variants (1)
Ac (3)
Ac-T (7)
Acalabrutinib + Obinutuzumab (4)
Acalabrutinib + Venetoclax (4)
Acalabrutinib Monotherapy (4)
Adjuvant Abemaciclib + Endocrine Therapy (2)
Adjuvant Endocrine Therapy (5)
Adjuvant Gist Therapy (0)
Adjuvant Ribociclib + Endocrine Therapy (1)
Adjuvant T-Dm1 After Neoadjuvant Therapy With Residual Disease (0)
All Maintenance (1)
All Regimens (0)
Alpelisib + Endocrine Therapy In Selected Breast Cancer Settings (1)
Alpelisib + Fulvestrant (1)
Anastrozole Monotherapy (3)
Androgen-Deprivation Regimens (2)
Apalutamide + Adt (1)
Apalutamide + Adt In Metastatic Hormone-Sensitive Disease (1)
Appetite-Supportive Care Protocols (3)
Atezolizumab + Bevacizumab (4)
Avelumab Maintenance After Platinum Chemotherapy In Urothelial Carcinoma (1)
Avelumab Monotherapy (1)
Azacitidine + Venetoclax (3)
Azacitidine Monotherapy (3)
Azacitidine-Based Aml/Mds Regimens (3)
Bendamustine + Rituximab (4)
Bendamustine + Rituximab (Br) (1)
Bendamustine-Based Lymphoma Regimens (1)
Bep (6)
Bicalutamide + Lhrh Agonist/Adt (1)
Bortezomib-Based Myeloma Regimens (3)
Bosutinib Monotherapy (0)
Braf-Targeted Colorectal Combinations (2)
Breast Cancer Anthracycline Regimens (1)
Cabazitaxel + Prednisone/Prednisolone (0)
Cabozantinib Monotherapy (3)
Capecitabine + Oxaliplatin Or Other Disease-Specific Combinations (3)
Capox + Bevacizumab (3)
Capox/Xelox (7)
Carboplatin + Gemcitabine (6)
Carboplatin + Pemetrexed (6)
Carboplatin + Pemetrexed + Pembrolizumab (0)
Carboplatin/Paclitaxel + Bevacizumab (4)
Carbotaxol (11)
Cetuximab + Radiation (2)
Chemoradiation (2)
Chemoradiation Regimens (4)
Chemotherapy + Dasatinib In Ph-Positive All (5)
Chemotherapy-Induced Nausea/Vomiting Prophylaxis (2)
Chop/R-Chop (3)
Cisplatin + Gemcitabine (4)
Cisplatin + Pemetrexed (4)
Cladribine Monotherapy (1)
Cmf (4)
Combination Antiemetic Regimens (2)
Combination Ar-Pathway Regimens (10)
Consolidation Regimens (1)
Consolidation/Maintenance-Related Flt3 Regimens (2)
Crizotinib Monotherapy (1)
Cybord (2)
Cybord/Vcd (3)
Cytoreduction Regimens (3)
Dacarbazine-Based Melanoma Regimens (1)
Dara-Rd (3)
Dara-Vrd (3)
Dasatinib Monotherapy (5)
Degarelix Monotherapy For Androgen Deprivation (0)
Dhap (4)
Disease-Specific Regimens (1)
Docetaxel + Adt (5)
Docetaxel + Ramucirumab (5)
Ec/Ec-T (1)
Endocrine Combinations (2)
Endocrine Therapy + Abemaciclib (2)
Endocrine Therapy Combinations (3)
Enzalutamide + Adt (0)
Enzalutamide Monotherapy Where Labeled (0)
Ep (2)
Erlotinib Monotherapy (5)
Everolimus + Endocrine Therapy (4)
Everolimus + Exemestane (4)
Exemestane + Everolimus (1)
Exemestane Monotherapy (1)
Fec/Fec-T (1)
Flag-Ida (1)
Flag-Ida Variants (1)
Folfiri (2)
Folfiri + Bevacizumab (4)
Folfiri + Cetuximab (2)
Folfirinox (6)
Folfox (6)
Folfox + Bevacizumab (4)
Folfox + Cetuximab (2)
Folfox-Like Combinations Are Not Paclitaxel Regimens (5)
Folfox-Like Combinations Are Not Standard Cisplatin Regimens (4)
Fulvestrant + Alpelisib (4)
Fulvestrant + Cdk4/6 Inhibitor (4)
Fulvestrant + Targeted Agents (4)
Gastric/Gej Her2 Regimens (6)
Gefitinib Monotherapy (3)
Gemcis/Cisgem (2)
Gemcitabine + Carboplatin (2)
Gemcitabine + Docetaxel (2)
Gemcitabine + Nab-Paclitaxel (2)
Goserelin + Tamoxifen/Aromatase Inhibitor (2)
Hairy Cell Leukemia Regimens (1)
Hidac (1)
Historically Used Hormonal Therapy (1)
Hormonal Therapy (3)
Hydroxyurea Monotherapy (3)
Hyper-Cvad (1)
Hyper-Cvad And Many Hematologic Regimens (2)
Hyper-Cvad Variants (4)
Ibrutinib + Bendamustine/Rituximab (0)
Ibrutinib + Rituximab (0)
Ibrutinib Monotherapy (0)
Imatinib Monotherapy (0)
Isa-Kd And Other Myeloma Combinations (1)
Kd (1)
Krd (1)
Lapatinib + Capecitabine (3)
Lapatinib + Trastuzumab (3)
Lenvatinib + Everolimus (0)
Lenvatinib + Pembrolizumab (0)
Lenvatinib Monotherapy (0)
Letrozole + Cdk4/6 Inhibitor (1)
Letrozole Monotherapy (1)
Leuprolide + Antiandrogen (2)
Leuprolide + Ar-Pathway Inhibitor (2)
Lymphoma Combinations (3)
Lymphoma/Leukemia Salvage (1)
Maintenance After Autologous Transplant (3)
Maintenance Combinations (0)
Maintenance In Ovarian Cancer (4)
Maintenance Rituximab (4)
Maintenance Temozolomide (3)
Melphalan/Prednisone/Thalidomide (0)
Metastatic Hr+/Her2- Endocrine Combinations (2)
Mopp (1)
Myeloma Combinations (0)
Myeloma Or Lymphoma Regimens In Selected Settings (0)
Nilotinib Monotherapy (2)
Nintedanib + Docetaxel (1)
Nivolumab + Cabozantinib (4)
Nivolumab + Chemotherapy (1)
Nivolumab + Ipilimumab (1)
Nivolumab + Relatlimab (1)
Not A Standard Contemporary First-Line Regimen In Most Major Guidelines (1)
Olaparib + Bevacizumab (7)
Olaparib + Endocrine Therapy In Selected Settings (7)
Olaparib Maintenance (7)
Older Combined Androgen Blockade Regimens (1)
Other Disease-Specific Combinations (4)
Other Disease-Specific Regimens (5)
Other Myeloma Combinations (6)
Ovarian Platinum Regimens (6)
Ovarian Suppression (2)
Ovarian Suppression + Tamoxifen (1)
Paclitaxel + Pembrolizumab (5)
Palbociclib + Fulvestrant (6)
Palbociclib + Letrozole (6)
Palbociclib + Trastuzumab ? Pertuzumab + Endocrine Therapy (6)
Pazopanib Monotherapy (0)
Pcv (1)
Pediatric All/Aml Combinations (0)
Pemetrexed Maintenance (0)
Ph-Positive Leukemia Regimens (0)
Platinum/Etoposide Regimens (2)
Platinum/Topotecan Regimens (0)
Pld + Bevacizumab (0)
Pld + Carboplatin (0)
Pomalidomide + Daratumumab + Dexamethasone (6)
Pomalidomide + Dexamethasone (6)
Post-Docetaxel Mcrpc Regimens (0)
Primary Prophylaxis After Myelosuppressive Chemotherapy (0)
R-Chop (4)
R-Chop Variants (3)
R-Cvp (4)
Radiotherapy-Induced Nausea Protocols (2)
Rd (3)
Regorafenib Monotherapy (2)
Relugolix + Androgen-Pathway Agents (2)
Relugolix Monotherapy For Adt (2)
Ribociclib + Aromatase Inhibitor (1)
Ribociclib + Fulvestrant (1)
Rucaparib Monotherapy (4)
Sarcoma Regimens (1)
Secondary Prophylaxis (0)
Selected Combinations Under Disease-Specific Labels (0)
Selected Net/Rcc Regimens (4)
Selected Pancreatic Cancer Combination With Gemcitabine (5)
Selected Prostate Cancer Regimens (1)
Selected Prostate Cancer Use Where Labeled (4)
Sequential Endocrine Therapy (3)
Small-Cell Lung Cancer Regimens (2)
Stupp Regimen (Temozolomide + Radiotherapy) (3)
Sunitinib Monotherapy (6)
T-Dm1 Monotherapy (0)
T-Dxd Monotherapy (0)
Tamoxifen Monotherapy (1)
Tc (10)
Tch (6)
Tch/Tchp (16)
Tchp (6)
Tchp Does Not Contain Doxorubicin (1)
Thalidomide + Dexamethasone (0)
Thp (6)
Topotecan Monotherapy (0)
Trastuzumab + Endocrine Therapy (6)
Trastuzumab + Pertuzumab + Taxane (0)
Trastuzumab + Taxane (6)
Tucatinib + Trastuzumab + Capecitabine (0)
Uncategorized (0)
Venetoclax + Azacitidine/Decitabine (0)
Venetoclax + Obinutuzumab (0)
Venetoclax + Rituximab (0)
Vip (2)
Vrd (6)
Weekly Paclitaxel + Trastuzumab (5)
Shopping cart
Your cart is empty
Continue Shopping
0
Cart
All
5-Fu/Leucovorin (2)
6-Mp-Containing Pediatric All Protocols (1)
7+3 (1)
7+3 + Midostaurin (2)
Abiraterone + Androgen-Deprivation Therapy (Adt) (10)
Abiraterone + Prednisone/Prednisolone (10)
Abvd (1)
Abvd Alternatives (1)
Abvd Variants (1)
Ac (3)
Ac-T (7)
Acalabrutinib + Obinutuzumab (4)
Acalabrutinib + Venetoclax (4)
Acalabrutinib Monotherapy (4)
Adjuvant Abemaciclib + Endocrine Therapy (2)
Adjuvant Endocrine Therapy (5)
Adjuvant Ribociclib + Endocrine Therapy (1)
All Maintenance (1)
Alpelisib + Endocrine Therapy In Selected Breast Cancer Settings (1)
Alpelisib + Fulvestrant (1)
Anastrozole Monotherapy (3)
Androgen-Deprivation Regimens (2)
Apalutamide + Adt (1)
Apalutamide + Adt In Metastatic Hormone-Sensitive Disease (1)
Appetite-Supportive Care Protocols (3)
Atezolizumab + Bevacizumab (4)
Avelumab Maintenance After Platinum Chemotherapy In Urothelial Carcinoma (1)
Avelumab Monotherapy (1)
Azacitidine + Venetoclax (3)
Azacitidine Monotherapy (3)
Azacitidine-Based Aml/Mds Regimens (3)
Bendamustine + Rituximab (4)
Bendamustine + Rituximab (Br) (1)
Bendamustine-Based Lymphoma Regimens (1)
Bep (6)
Bicalutamide + Lhrh Agonist/Adt (1)
Bortezomib-Based Myeloma Regimens (3)
Braf-Targeted Colorectal Combinations (2)
Breast Cancer Anthracycline Regimens (1)
Cabozantinib Monotherapy (3)
Capecitabine + Oxaliplatin Or Other Disease-Specific Combinations (3)
Capox + Bevacizumab (3)
Capox/Xelox (7)
Carboplatin + Gemcitabine (6)
Carboplatin + Pemetrexed (6)
Carboplatin/Paclitaxel + Bevacizumab (4)
Carbotaxol (11)
Cetuximab + Radiation (2)
Chemoradiation (2)
Chemoradiation Regimens (4)
Chemotherapy + Dasatinib In Ph-Positive All (5)
Chemotherapy-Induced Nausea/Vomiting Prophylaxis (2)
Chop/R-Chop (3)
Cisplatin + Gemcitabine (4)
Cisplatin + Pemetrexed (4)
Cladribine Monotherapy (1)
Cmf (4)
Combination Antiemetic Regimens (2)
Combination Ar-Pathway Regimens (10)
Consolidation Regimens (1)
Consolidation/Maintenance-Related Flt3 Regimens (2)
Crizotinib Monotherapy (1)
Cybord (2)
Cybord/Vcd (3)
Cytoreduction Regimens (3)
Dacarbazine-Based Melanoma Regimens (1)
Dara-Rd (3)
Dara-Vrd (3)
Dasatinib Monotherapy (5)
Dhap (4)
Disease-Specific Regimens (1)
Docetaxel + Adt (5)
Docetaxel + Ramucirumab (5)
Ec/Ec-T (1)
Endocrine Combinations (2)
Endocrine Therapy + Abemaciclib (2)
Endocrine Therapy Combinations (3)
Ep (2)
Erlotinib Monotherapy (5)
Everolimus + Endocrine Therapy (4)
Everolimus + Exemestane (4)
Exemestane + Everolimus (1)
Exemestane Monotherapy (1)
Fec/Fec-T (1)
Flag-Ida (1)
Flag-Ida Variants (1)
Folfiri (2)
Folfiri + Bevacizumab (4)
Folfiri + Cetuximab (2)
Folfirinox (6)
Folfox (6)
Folfox + Bevacizumab (4)
Folfox + Cetuximab (2)
Folfox-Like Combinations Are Not Paclitaxel Regimens (5)
Folfox-Like Combinations Are Not Standard Cisplatin Regimens (4)
Fulvestrant + Alpelisib (4)
Fulvestrant + Cdk4/6 Inhibitor (4)
Fulvestrant + Targeted Agents (4)
Gastric/Gej Her2 Regimens (6)
Gefitinib Monotherapy (3)
Gemcis/Cisgem (2)
Gemcitabine + Carboplatin (2)
Gemcitabine + Docetaxel (2)
Gemcitabine + Nab-Paclitaxel (2)
Goserelin + Tamoxifen/Aromatase Inhibitor (2)
Hairy Cell Leukemia Regimens (1)
Hidac (1)
Historically Used Hormonal Therapy (1)
Hormonal Therapy (3)
Hydroxyurea Monotherapy (3)
Hyper-Cvad (1)
Hyper-Cvad And Many Hematologic Regimens (2)
Hyper-Cvad Variants (4)
Isa-Kd And Other Myeloma Combinations (1)
Kd (1)
Krd (1)
Lapatinib + Capecitabine (3)
Lapatinib + Trastuzumab (3)
Letrozole + Cdk4/6 Inhibitor (1)
Letrozole Monotherapy (1)
Leuprolide + Antiandrogen (2)
Leuprolide + Ar-Pathway Inhibitor (2)
Lymphoma Combinations (3)
Lymphoma/Leukemia Salvage (1)
Maintenance After Autologous Transplant (3)
Maintenance In Ovarian Cancer (4)
Maintenance Rituximab (4)
Maintenance Temozolomide (3)
Metastatic Hr+/Her2- Endocrine Combinations (2)
Mopp (1)
Nilotinib Monotherapy (2)
Nintedanib + Docetaxel (1)
Nivolumab + Cabozantinib (4)
Nivolumab + Chemotherapy (1)
Nivolumab + Ipilimumab (1)
Nivolumab + Relatlimab (1)
Not A Standard Contemporary First-Line Regimen In Most Major Guidelines (1)
Olaparib + Bevacizumab (7)
Olaparib + Endocrine Therapy In Selected Settings (7)
Olaparib Maintenance (7)
Older Combined Androgen Blockade Regimens (1)
Other Disease-Specific Combinations (4)
Other Disease-Specific Regimens (5)
Other Myeloma Combinations (6)
Ovarian Platinum Regimens (6)
Ovarian Suppression (2)
Ovarian Suppression + Tamoxifen (1)
Paclitaxel + Pembrolizumab (5)
Palbociclib + Fulvestrant (6)
Palbociclib + Letrozole (6)
Palbociclib + Trastuzumab ? Pertuzumab + Endocrine Therapy (6)
Pcv (1)
Platinum/Etoposide Regimens (2)
Pomalidomide + Daratumumab + Dexamethasone (6)
Pomalidomide + Dexamethasone (6)
R-Chop (4)
R-Chop Variants (3)
R-Cvp (4)
Radiotherapy-Induced Nausea Protocols (2)
Rd (3)
Regorafenib Monotherapy (2)
Relugolix + Androgen-Pathway Agents (2)
Relugolix Monotherapy For Adt (2)
Ribociclib + Aromatase Inhibitor (1)
Ribociclib + Fulvestrant (1)
Rucaparib Monotherapy (4)
Sarcoma Regimens (1)
Selected Net/Rcc Regimens (4)
Selected Pancreatic Cancer Combination With Gemcitabine (5)
Selected Prostate Cancer Regimens (1)
Selected Prostate Cancer Use Where Labeled (4)
Sequential Endocrine Therapy (3)
Small-Cell Lung Cancer Regimens (2)
Stupp Regimen (Temozolomide + Radiotherapy) (3)
Sunitinib Monotherapy (6)
Tamoxifen Monotherapy (1)
Tc (10)
Tch (6)
Tch/Tchp (16)
Tchp (6)
Tchp Does Not Contain Doxorubicin (1)
Thp (6)
Trastuzumab + Endocrine Therapy (6)
Trastuzumab + Taxane (6)
Vip (2)
Vrd (6)
Weekly Paclitaxel + Trastuzumab (5)
Login
Enter your username and password to login.
Remember me
Lost password?
Welcome to our online store!
Zmdi-facebook
Zmdi-twitter
Zmdi-youtube-play
Zmdi-instagram
0
0
₹
0.00
Your cart is empty
Continue Shopping
Home Medicine
Shop
Page
About Us
Contact Us
FAQs
Terms Of Use
Recently Viewed
You have no recent viewed item.
Shop
Home
Mopp
Showing the single result
Default sorting
Sort by popularity
Sort by latest
Sort by price: low to high
Sort by price: high to low
-26%
Quick View
HODPRO 50MG CAPSULE
₹
325.00
Current price is: ₹325.00.
₹
438.75
Original price was: ₹438.75.
Add to cart
